Brazilian Journal of Pain
https://brjp.org.br/article/doi/10.5935/2595-0118.20210011
Brazilian Journal of Pain
Original Article

Factors that influence the quality of life in neuropathic, musculoskeletal, and oncological pain

Fatores que influenciam a qualidade de vida em dor neuropática, musculoesquelética e oncológica

Ana Carolina Rodrigues; Ana Marcia Rodrigues Cunha; José Eduardo Nogueira Forni; Lilian Andreia Chessa Dias; Paulo Rafael Condi; Marielza Regina Ismael Martins

http://dx.doi.org/10.5935/2595-0118.20210011 BrJP, vol.4, n1, p.31-36, 2021
PDF English
PDF Português
SciELO
Downloads: 0
Views: 603

Abstract

BACKGROUND AND OBJECTIVES: The clinical practice of analgesia in chronic pain is often deficient or ineffective, either due to the subjectivity or presence of potentiating factors. The most common chronic pains are musculoskeletal, neuropathic, and oncological. This research aimed at understanding the aspects that intersperse the process of pain and how they interfere in quality of life.

METHODS: Descriptive, cross-sectional, exploratory study with a sample of 44 patients,15 with musculoskeletal pain, 15 with oncological pain and 14 with neuropathic pain, belonging to the Base Hospital Pain Clinic in São José do Rio Preto/SP. Data were collected through specific semi-structured interviews, self-assessment and application of instruments: Visual Analog Scale, Health-Related Quality of Life Questionnaire, Morisky and Green Drug Treatment Adherence Test, Questionnaire for Diagnosis of Neuropathic Pain, Epworth Sleepiness Scale, Tampa Kinesiophobia Scale, Beck Anxiety Inventory, and Beck Depression Inventory.

RESULTS: The data analysis revealed poor quality of life in 61.36% of the patients, and this situation was even more serious for patients with neuropathic pain. The association between quality of life and the analyzed factors was statistically significant in terms of adherence to treatment, pain levels, sleepiness, anxiety and depression. Individuals with neuropathic pain were more affected, except for kinesiophobia, which had more incidence in individuals with musculoskeletal pain.

CONCLUSION: Data revealed that all types of pain considerably decrease quality of life, and it’s more evident in individuals with neuropathic pain.

Keywords

Cancer pain, Chronic pain, Musculoskeletal pain, Pain, Quality of life

Resumo

JUSTIFICATIVA E OBJETIVOS: A prática clínica no tratamento da dor crônica é frequentemente deficiente ou ineficaz, seja pela subjetividade ou pela presença de fatores potencializadores. As dores crônicas mais comuns são a musculoesquelética, a neuropática e a oncológica. Este estudo teve como objetivo conhecer os aspectos que entremeiam o processo de dor e como tal condição interfere na qualidade de vida.

MÉTODOS: Estudo descritivo, transversal e exploratório que incluiu 44 pacientes, sendo 15 com dor musculoesquelética, 15 com dor oncológica e 14 com dor neuropática. Os dados foram coletados por meio de entrevista específica semiestruturada, autoavaliação e aplicação dos instrumentos: Escala Analógica Visual, Health-related Quality of Life Questionnaire, Morisky and Green Drug Treatment Adherence Test, Questionnaire for Diagnosis of Neuropathic Pain, Epworth Sleepiness Scale, Tampa Kinesiophobia Scale, Beck Anxiety Inventory e Beck Depression Inventory.

RESULTADOS: A análise dos dados revelou baixa qualidade de vida para 61,36% dos pacientes, sendo mais grave para os portadores de dor neuropática. A associação da qualidade de vida com os fatores analisados foi estatisticamente significante quanto à adesão ao tratamento, nível de dor, sonolência, ansiedade e depressão. Os indivíduos com dor neuropática foram os mais afetados, exceto pela cinesiofobia, que teve maior ocorrência nos indivíduos com dor musculoesquelética.

CONCLUSÃO: Os três tipos de dor diminuem consideravelmente a qualidade de vida dos pacientes, sendo a redução mais evidente nos portadores de dor neuropática.

Palavras-chave

Dor, Dor crônica, Dor do câncer, Dor musculoesquelética, Qualidade de vida

References

Slattery BW. Investigating the effectiveness of an online acceptance and commitment therapy (ACT) intervention versus a waiting list control condition on pain interference and quality of life in adults with chronic pain and multimorbidity protocol for a randomised controlled trial. BMJ Open. 2019;9(5).

2020 Ano mundial para a Prevenção da Dor. .

Mills SEE, Nicolson KP, Smith BH. Chronic pain a review of its epidemiology and associated factors in population-based studies. BrJ Anaesth. 2019;123(2):e273-83.

Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2018. Lancet. 2018;392(10149):760-75.

Perrot S, Cohen M, Barke A, Korwisi B, Rief W, Treede RD. The IASP classification of chronic pain for ICD-11 chronic secondary musculoskeletal pain. Pain. 2019;160(1):77-82.

Bennett MI, Kaasa S, Barke A, Korwisi B, Rief W, Treede RD. The IASP classification of chronic pain for ICD-11 chronic cancer-related pain. Pain. 2019;160(1):38-44.

Barbosa IM, Vendas DS, Oliveira LM, Sampaio DV, Milhome AG. Pain in onco-hematologic patients and its association with analgesia. Rev Dor. 2016;17(3):178-82.

Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI. The IASP classification of chronic pain for ICD-11 chronic neuropathic pain. Pain. 2019;160(1):53-9.

Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002.

Pereira FG, França MH, Paiva MCA, Andrade LH, Viana MC. Prevalence and clinical profile of chronic pain and its association with mental disorders. Rev Saude Publica. 2017;17:96.

Majedi H, Amini MH, Yousefshahi F. Predicting factors od pain duration in patients with chronic pain a large population-based study. Anesth Pain Med. 2020;10(1).

Majedi H, Dehghani SS, Soleman-Jahi S. Assessment of factors predicting inadequate pain management in chronic pain patients. Anesth Pain Med. 2019;9(6).

de Souza JB, Grossmann E, Perissinoti DMN. Prevalence of chronic pain, treatment, perception, and interference on life activities Brazilian population-based survey. Pain Res Manag. 2017;2017:4643830.

Vasconcelos FH, Araújo GC. Prevalence of chronic pain in Brazil a descriptive study. BrJP. 2018;1(2):176-9.

Dutra FCMS, Costa LC, Sampaio RF. A influência do afastamento do trabalho na percepção de saúde e qualidade de vida de indivíduos adultos. Fisioter Pesqui. 2016;23(1):98-104.

Geurts JW, Willems PC, Lockwood C. Patient expectations for management of chronic non-cancer pain A systematic review. Health Expect. 2017;20(6):1201-17.

Wiffen PJ, Derry S, Bell RF, Arroz AS, Tolle TR, Phillips T. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6(6):CD007938.

Ferreira KS, Speciali JG. Epidemiologia da dor crônica no consultório de um neurologista especialista em dor. Arq Neuro-Psiquiatr. 2015;73(7):582-5.

Nijs J, Leysen L, Vanlauwe J. Treatment of central sensitization in patients with chronic pain time for change?. Expert Opin Pharmacother. 2019;20(16):1961-70.

Timmerman L, Stronks DL, Groeneweg JG, Huygen FJ. Prevalence and determinants of medication non-adherence in chronic pain patients a systematic review. Acta Anaesthesiol Scand. 2016;60(4):416-31.

Sampaio R, Azevedo LF, Dias CC, Castro Lopes JM. Non-adherence to pharmacotherapy a prospective multicentre study about its incidence and its causes perceived by chronic pain patients. Patient Prefer Adherence. 2020;14:321-32.

Souza JB, Carqueja CL, Baptista AF. Reabilitação física no tratamento de dor neuropática. Rev Dor. 2016;17(1):85-90.

Ambrose KR, Golightly YM. Physical exercise as non-pharmacological treatment of chronic pain why and when. Best Pract Res Clin Rheumatol. 2015;29(1):120-30.

Tonial LF, Stechman Neto J, Hummig W. Dor crônica relacionada à qualidade do sono. Einstein. 2014;12(2):159-63.

Meints SM, Edwards RR. Evaluating psychosocial contributions to chronic pain outcomes. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(B):168-82.

Hirotsu C, Frange C, Hirata PH, Cremaschi RC, Coelho FM, Andersen ML. Sleepiness comorbid to musculoskeletal pain is associated with worse quality of life and mood symptoms in a general population sample. Sleep Sci. 2019;12(2):79-87.

Simpson NS, Scott-Sutherland J, Gautam S, Sethna N, Haack M. Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization. Pain. 2018;159(1):33-40.

The role of sleep quality and fatigue on the benefits of an interdisciplinary treatment for adults with chronic pain. Pain Pract. 2019;19(4):354-62.

Campolina AG, Lopez RVM, Nardi EP, Ferraz MB. Quality of life in a sample of Brazilian adults using the generic SF-12 questionnaire. Rev Assoc Med Bras 1992. 2018;64(3):234-42.

Ulug N, Yakut Y, Alemdaroglu I, Yilmaz Ö. Comparison of pain, kinesiophobia and quality of life in patients with low back and neck pain. J PhysTherSci. 2016;28(2):665-70.

Luque-Suarez A, Martinez-Calderon J, Falla D. Role of kinesiophobia on pain, disability and quality of life in people suffering from chronic musculoskeletal pain a systematic review. Br J Sports Med. 2019;53(9):554-9.

Vachon-Presseau E, Tétreault P, Petre B. Corticolimbic anatomical characteristics predetermine risk for chronic pain. Brain. 2016;139:1958-70.

Nesse RM, Schulkin J. An evolutionary medicine perspective on pain and its disorders. Philos Trans R Soc Lond B Biol Sci. 2019;374(1785):20190288.

Gerrits MM, van Marwijk HW, van Oppen P. Longitudinal association between pain, and depression and anxiety over four years. J Psychosom Res. 2015;78(1):64-70.

Edge R, Mills R, Tennant A, Diggle PJ, Young CA. Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease A national study reconciling previous conflicting literature. J Neurol. 2020;267(3):607-15.

Khammissa RAG, Ballyram R, Fourie J, Bouckaert M, Lemmer J, Feller L. Selected pathobiological features and principles of pharmacological pain management. J IntMed Res. 2020;48(5):300060520903653.

Oliveira Jr JO. JO, Corrêa CF, Ferreira JA Tratamento invasivo para o controle da dor neuropática. Rev Dor. 2016;17(1):98-106.

Submitted date:
07/13/2020

Accepted date:
01/11/2021

608739bca953957886796414 brjp Articles
2595-3192 (Electronic) 2595-0118 (Printed)
BrJP ©2024 All rights reserved.

BrJP

Share this page
Page Sections